David H. Mack
2022
In 2022, David H. Mack earned a total compensation of $3.6M as President, Chief Executive Officer and Director at PMV Pharmaceuticals, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,275 |
|---|---|
| Option Awards | $2,814,415 |
| Salary | $563,750 |
| Total | $3,576,440 |
Mack received $2.8M in option awards, accounting for 79% of the total pay in 2022.
Mack also received $198.3K in non-equity incentive plan and $563.8K in salary.
Rankings
In 2022, David H. Mack's compensation ranked 989th out of 5,538 executives tracked by ExecPay. In other words, Mack earned more than 82.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 989 out of 5,538 | 82nd |
Division Manufacturing | 461 out of 3,000 | 85th |
Major group Chemicals And Allied Products | 164 out of 1,350 | 88th |
Industry group Drugs | 147 out of 1,253 | 88th |
Industry Pharmaceutical Preparations | 107 out of 907 | 88th |
Source: SEC filing on April 28, 2023.
Mack's colleagues
We found two more compensation records of executives who worked with David H. Mack at PMV Pharmaceuticals in 2022.